Enhanced anticancer effect of ABT-737 in combination with naringenin on gastric cancer cells

Experimental and Therapeutic Medicine

Volumn 11, Issue 2, 2016, Pages 669-673

  Zhang, Haiyang ^a   Zhong, Xia ^a   Zhang, Xiao ^b   Shang, Deya ^a   Zhou, Yi ^a   Zhang, Chunqing ^a  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^b Shandong Center for Disease Control and Prevention   (China)

Author keywords

ABT 737; Anticancer; Gastric cancer; Naringenin

Indexed keywords

4 [4 (4' CHLORO 2 BIPHENYLYLMETHYL) 1 PIPERAZINYL] N [4 [3 DIMETHYLAMINO 1 (PHENYLTHIOMETHYL)PROPYLAMINO] 3 NITROBENZENESULFONYL]BENZAMIDE; CASPASE 3; NARINGENIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BCL 2; PROTEIN KINASE B; PROTEIN P53;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL VIABILITY; CELL VIABILITY ASSAY; CONTROLLED STUDY; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; STOMACH CANCER; TUMOR GROWTH; WESTERN BLOTTING;

EID: 84951020954     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2015.2912     Document Type: Article

References (28)

1. Li Y, Yan PW, Huang XE and Li CG: MDR1 gene C3435T polymorphism is associated with clinical outcomes in gastric cancer patients treated with postoperative adjuvant chemotherapy. Asian Pac J Cancer Prev 12: 2405-2409, 2011.
2. Ferro A, Peleteiro B, Malvezzi M, Bosetti C, Bertuccio P, Levi F, Negri E, La Vecchia C and Lunet N: Worldwide trends in gastric cancer mortality (1980-2011), with predictions to 2015, and incidence by subtype. Eur J Cancer 50: 1330-1344, 2014.
3. American Cancer Society: Survival rates for stomach cancer, by stage. www.cancer.org/cancer/stomachcancer/detailedguide/stomach-cancer-survival-rates. Accessed June 24, 2014.
4. Shan YS, Hsu HP, Lai MD, Yen MC, Luo YP and Chen YL: Increased expression of argininosuccinate synthetase protein predicts poor prognosis in human gastric cancer. Oncology Rep 33: 49-57, 2015.
5. Yuan J, Li W, Tian Y and Wang X: Anti-proliferative effect of Flos Albiziae flavonoids on the human gastric cancer SGC-7901 cell line. Exp Ther Med 5: 51-56, 2013.
6. Romagnolo DF and Selmin OI: Flavonoids and cancer prevention: A review of the evidence. J Nutr Gerontol Geriatr 31: 206-238, 2012.
7. Ekambaram G, Rajendran P, Magesh V and Sakthisekaran D: Naringenin reduces tumor size and weight lost in N-methyl-N'-nitro-N-nitrosoguanidine-induced gastric carcinogenesis in rats. Nutr Res 28: 106-112, 2008.
8. Liao AC, Kuo CC, Huang YC, Yeh CW, Hseu YC, Liu JY and Hsu LS: Naringenin inhibits migration of bladder cancer cells through downregulation of AKT and MMP2. Mol Med Rep 10: 1531-1536, 2014.
9. Hatkevich T, Ramos J, Santos-Sanchez I and Patel YM: A naringenin-tamoxifen combination impairs cell proliferation and survival of MCF-7 breast cancer cells. Exp Cell Res 327: 331-339, 2014.
10. Ahamad MS, Siddiqui S, Jafri A, Ahmad S, Afzal M and Arshad M: Induction of apoptosis and antiproliferative activity of naringenin in human epidermoid carcinoma cell through ROS generation and cell cycle arrest. PloS one 9: e110003, 2014.
11. Arul D and Subramanian P: Naringenin (citrus flavonone) induces growth inhibition, cell cycle arrest and apoptosis in human hepatocellular carcinoma cells. Pathol Oncol Res 19: 763-770, 2013.
12. Kang MH and Reynolds CP: Bcl-2 inhibitors: Targeting mitochondrial apoptotic pathways in cancer therapy. Clin Cancer Res 15: 1126-1132, 2009.
13. Tahir SK, Yang X, Anderson MG, Morgan-Lappe SE, Sarthy AV, Chen J, Warner RB, Ng SC, Fesik SW, Elmore SW, et al: Influence of Bcl-2 family members on the cellular response of small-cell lung cancer cell lines to ABT-737. Cancer Res 67: 1176-1183, 2007.
14. Konopleva M, Contractor R, Tsao T, Samudio I, Ruvolo PP, Kitada S, Deng X, Zhai D, Shi YX, Sneed T, et al: Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia. Cancer Cell 10: 375-388, 2006.
15. Bodet L, Gomez-Bougie P, Touzeau C, Dousset C, Descamps G, Maïga S, Avet-Loiseau H, Bataille R, Moreau P, Le Gouill S, et al: ABT-737 is highly effective against molecular subgroups of multiple myeloma. Blood 118: 3901-3910, 2011.
16. van Delft MF, Wei AH, Mason KD, Vandenberg CJ, Chen L, Czabotar PE, Willis SN, Scott CL, Day CL, Cory S, et al: The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized. Cancer cell 10: 389-399, 2006.
17. Sun XP, Zhang X, He C, Qiao H, Jiang X, Jiang H and Sun X: ABT-737 synergizes with arsenic trioxide to induce apoptosis of gastric carcinoma cells in vitro and in vivo. J Int Med Res 40: 1251-1264, 2012.
18. Li RF, Feng YQ, Chen JH, Ge LT, Xiao SY and Zuo XL: Naringenin suppresses K562 human leukemia cell proliferation and ameliorates Adriamycin-induced oxidative damage in polymorphonuclear leukocytes. Exp Ther Med 9: 697-706, 2015.
19. Park JH, Jin CY, Lee BK, Kim GY, Choi YH and Jeong YK: Naringenin induces apoptosis through downregulation of Akt and caspase-3 activation in human leukemia THP-1 cells. Food Chem Toxicol 46: 3684-3690, 2008.
20. Parrondo R, de Las Pozas A, Reiner T and Perez-Stable C: ABT-737, a small molecule Bcl-2/Bcl-xL antagonist, increases antimitotic-mediated apoptosis in human prostate cancer cells. PeerJ 1: e144, 2013.
21. Cristofanon S and Fulda S: ABT-737 promotes tBid mitochondrial accumulation to enhance TRAIL-induced apoptosis in glioblastoma cells. Cell Death Dis 3: e432, 2012.
22. Yu DH, Ma CH, Yue ZQ, Yao X and Mao CM: Protective effect of naringenin against lipopolysaccharide-induced injury in normal human bronchial epithelium via suppression of MAPK signaling. Inflammation 38: 195-204, 2015.
23. Kapoor R, Rizvi F and Kakkar P: Naringenin prevents high glucose-induced mitochondria-mediated apoptosis involving AIF, Endo-G and caspases. Apoptosis 18: 9-27, 2013.
24. Kruiswijk F, Labuschagne CF and Vousden KH: p53 in survival, death and metabolic health: A lifeguard with a licence to kill. Nat Rev Mol Cell Biol 16: 393-405, 2015.
25. Warfel NA and Kraft AS: PIM kinase (and Akt) biology and signaling in tumors. Pharmacol Ther 151: 41-49, 2015.
26. Alam MA, Subhan N, Rahman MM, Uddin SJ, Reza HM and Sarker SD: Effect of citrus flavonoids, naringin and naringenin, on metabolic syndrome and their mechanisms of action. Adv Nutr 5: 404-417, 2014.
27. Sabarinathan D, Mahalakshmi P and Vanisree AJ: Naringenin promote apoptosis in cerebrally implanted C6 glioma cells. Mol Cell Biochem 345: 215-222, 2010.
28. Ekambaram G, Rajendran P, Devaraja R, Muthuvel R and Sakthisekaran D: Impact of naringenin on glycoprotein levels in N-methyl-N'-nitro-N-nitrosoguanidine-induced gastric carcinogenesis in rats. Anticancer Drugs 19: 885-890, 2008.